Open Access<p>NY-ESO-1 Protein Vaccine Combining Alum, CpG ODN, and HH2 Complex Adjuvant Induces Protective and Therapeutic Anti-Tumor Responses in Murine Multiple Myeloma</p>
Author(s) -
Hao Wang,
Wei Huang,
Hua Gao,
Ting Ting Liu
Publication year - 2020
Publication title -
oncotargets and therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.054
H-Index - 60
ISSN - 1178-6930
DOI - 10.2147/ott.s255713
Subject(s) - adjuvant , cpg oligodeoxynucleotide , medicine , immune system , alum , immunogenicity , cancer research , immunology , antibody , biology , chemistry , gene expression , biochemistry , dna methylation , organic chemistry , gene
NY-ESO-1 is an ideal target for multiple myeloma immunotherapy. Alum, CpG ODN and HH2 complex is a safe and effective adjuvant for cancer vaccine.